Filter results
You can narrow down the results using the filters
Audience
Topics
Our work
1243 results
-
$2.6 million for life-improving brain cancer research
The Australian Government is providing $2.6 million for the latest information technology to improve the lives of people who have survived brain cancer. -
ATAGI statement and clinical guidance on AstraZeneca COVID-19 vaccine following European Medicines Agency (EMA) safety review
This statement from the Australian Technical Advisory Group on Immunisation (ATAGI) updates advice previous provided on 16 March. It follows the European Medicines Agency (EMA) safety review of the AstraZeneca COVID-19 vaccine. -
Early advice on 2021 influenza vaccination
Vaccination against influenza remains important this year. Vaccination experts recommend influenza vaccination for all people aged 6 months and over. The National Immunisation Program (NIP) funds influenza vaccines for people most at risk. -
COVID-19 vaccination appointments to be available at GP-led respiratory clinics from 19 March 2021
COVID-19 vaccination appointments will be available at GP-led respiratory clinics from 19 March 2021. Find out more. -
$15 million to support innovative therapies for mental illness
The Australian Government has announced a $15 million competitive grant round to kick start clinical trials exploring the use of combination therapies to treat mental illnesses. -
$12.6 million grant opportunity for international clinical trial collaborations
A new Medical Research Future Fund (MRFF) grant opportunity is supporting Australian researchers to lead, and participate in, international collaborative clinical trials. -
General Practices join the COVID-19 vaccination program
Australians eligible for Phase 1b will be able to find a vaccination provider through the new national vaccination information and location service. -
ATAGI statement in response to European decisions about the AstraZeneca vaccine
A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding overnight decisions in Europe suspending the use of the AstraZeneca vaccine. -
Get involved in National Advance Care Planning Week 2021
Important life choices are planned, not left to chance. Find out what you can do today to ensure more control over your health care choices into the future. Whether it’s for you or someone you love, get involved in National Advance Care Planning Week from 22–26 March 2021. -
Medicare Benefits Schedule Electrocardiogram Review Committee – expressions of interest now closed – submissions open until 1 April 2021
Nominations for the Electrocardiogram (ECG) Review Committee have now closed. Nominations are currently being reviewed and nominees will be notified of the outcome of their nomination as soon as possible. -
Presentation about Australia's COVID-19 vaccine rollout
A presentation about Australia's COVID-19 vaccine rollout is now available to view or download. -
Over $1.1 billion to extend Australia's COVID-19 health response
The Prime Minister has announced the Government will invest more than $1.1 billion to extend Australia's national COVID-19 health response and suppression strategy. Find out more. -
Is it true? Countering the misinformation on COVID-19 vaccines
Is it true? is a new feature on our website to help answer questions people may have about COVID-19 vaccines and respond to vaccine misinformation they may have heard. Find out more. -
Consultation is open on the draft National Preventive Health Strategy
Public consultation on the draft Strategy is open until 19 April 2021. The Strategy aims to improve the health of all Australians at all stages of life. -
Prime Minister’s update following the National Cabinet meeting on 5 March 2021
Read the Prime Minister’s update following the National Cabinet meeting on 5 March 2021. -
Clinical update: ATAGI advice on seasonal influenza vaccines in 2021
The Australian Technical Advisory Group on Immunisation has provided advice to support immunisation providers ahead of this year’s influenza season. -
New PBS listings for multiple sclerosis, asthma and diabetes medicines
The Australian Government has listed a range of medicines for treating multiple sclerosis, asthma and diabetes on the Pharmaceutical Benefits Scheme (PBS). The listings will provide valuable support for more than 51,800 Australians living with these conditions, saving them up to $29,000 a year.
-
New listing provides relief for Australians with severe eczema
The Government has added a life-changing new eczema medicine to the Pharmaceutical Benefits Scheme (PBS). The $270 million in funding to list the medicine will help up to 3,600 Australians over 12 years of age living with severe eczema.
-
Next phase of COVID-19 vaccination campaign begins
The second phase of the Australian Government's COVID-19 vaccination campaign has launched. Find out more about the campaign, including when different priority groups will receive the vaccine. -
$100 million for medical research technology
The Australian Government is investing $100 million into the development of new technologies to improve the diagnosis and treatment of stroke, epilepsy and lung disease, including COVID-19. -
First COVID-19 vaccinations in Australia
Find out more about the launch of Australia's COVID-19 vaccination program. -
New variants of SARS-CoV-2 and implications for infection prevention and control practices
A statement from the Infection Control Expert Group (ICEG) on transmission of SARS-CoV-2. -
COVID-19 vaccine rollout on track to begin 22 February
Find out who the initial doses of COVID-19 vaccine will go to. -
Update for Aboriginal and Torres Strait Islander peoples about Australia’s COVID-19 vaccines
The COVID-19 vaccine rollout is starting in February. Getting a vaccine is a safe and effective way of protecting yourself from getting really sick from COVID-19. Encourage your family, Elders and community to get vaccinated when it is their turn so they are protected from it as well. -
Help people hear better
Are you a healthcare professional caring for Aboriginal and Torres Strait Islander people?
You could be eligible for EarTrain: a series of free training modules on how to identify, manage and treat ear disease and hearing loss.